Using the classic procedure of blood monocyte derived DC culture (in the presence of IL-4 and GM-CSF), the ex vivo yield of DCs was found to be significantly reduced in patients with cancer, particularly in those with breast cancer. This evidence concerns the gene IL4 and cancer.